Antiphospholipid Antibodies and Recurrent Pregnancy Loss
- 1 June 1989
- journal article
- review article
- Published by Wiley in American Journal of Reproductive Immunology
- Vol. 20 (2) , 52-67
- https://doi.org/10.1111/j.1600-0897.1989.tb00639.x
Abstract
Antiphospholipid antibodies (APA) have recently been linked to a variety of clinical findings including arterial and venous thrombosis, recurrent spontaneous abortions and fetal loss, as well as thrombocytopenia. These observations have stimulated multidisciplinary interest in the laboratory identification of APA and the clinical management of patients with positive tests for APA.Keywords
This publication has 125 references indexed in Scilit:
- INTRAVENOUS GAMMAGLOBULIN, ANTIPHOSPHOLIPID ANTIBODIES, AND THROMBOCYTOPENIAThe Lancet, 1988
- Role of Lupus Anticoagulant and Autoimmunity in Recurrent Pregnancy LossSeminars in Reproductive Medicine, 1988
- SYNDROME OF THE BLACK SWANRheumatology, 1987
- Anticardiolipin antibody testing: the need for standardizationArthritis & Rheumatism, 1987
- Anticardiolipin Antibodies in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1986
- Thrombosis, recurrent abortions and intrauterine foetal death in a patient with lupus anticoagulantClinical Rheumatology, 1985
- Antiphospholipid Antibodies and PregnancyNew England Journal of Medicine, 1985
- Lupus Anticoagulant, Thrombosis, and Fetal LossNew England Journal of Medicine, 1985
- Obstetric Complications Associated with the Lupus AnticoagulantNew England Journal of Medicine, 1985
- Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus ErythematosusNew England Journal of Medicine, 1985